Published Date: 26 Apr 2023
Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.
Read Full NewsPain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.
Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.
New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.
The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.
1.
Researchers discover cellular 'doorway' exploited by cancer-causing virus
2.
Stevia leaf extract has potential as anticancer treatment, researchers find
3.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
4.
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant
5.
According to research, the mineralization of the bone matrix controls the growth of tumor cells.
1.
Comprehensive Developments in Hematology in Daily Practice
2.
Liquid Biopsies in Hematology: A Window into the Disease
3.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
4.
The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide
5.
Progressive Trends in Hematology and Patient Outcomes
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
2.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation